期刊文献+

1例胰岛素过敏合并胰岛素自身抗体阳性的暴发性1型糖尿病患者的药学监护 被引量:2

Pharmaceutical care for a case of fulminant type 1 diabetes with insulin allergy and positive insulin autoantibodies
下载PDF
导出
摘要 目的探讨1例胰岛素过敏合并胰岛素自身抗体阳性的暴发性1型糖尿病患者的用药调整与实施药学监护的方案。方法临床药师参与整个治疗过程,查阅相关文献,根据患者血糖波动特点提出相应建议。结果医师和患者认可临床药师的建议与药学监护,患者血糖控制平稳。结论临床药师运用药学知识,协助医师共同制定治疗方案,对患者进行药学监护,保障了患者合理用药安全。 Objective To investigate the importance of medication adjustment and pharmaceutical care for a case of fulminant type 1 diabetes with insulin allergy and positive insulin autoantibodies.Methods Clinical pharmacists participated in the whole process of treatment,reviewed the related literature and offered recommendations according to the fluctuations of the patient’s blood glucose.Results The physicians and patient took the advice of the clinical pharmacists.The blood glucose of the patient was brought under control.Conclusion By using the intimate knowledge of pharmacy,clinical pharmacists can assist physicians in establishing the therapeutic regimen and performing pharmaceutical monitoring of the patient,which can help ensure rational drug use.
作者 唐彦 王嘉麟 周婧雅 赵维纲 杜博冉 胡丹丹 杨丽萍 杨莹莹 赵喆 袁涛 TANG Yan;WANG Jialin;ZHOU Jingya;ZHAO Weigang;DU Boran;HU Dandan;YANG Liping;YANG Yingying;ZHAO Zhe;YUAN Tao(Department of Pharmacy,Peking Union Hospital,Chinese Academy of Medical Sciences,Beijing 100010,China;Department of Pharmacy,Jilin People’s Hospital,Jilin Jilin 132001,China;Peking Union Medical College Hospital,Chinese Academy of Medical Sciences,Beijing 100730,China;WHO 1Collaborating Center on Family Classification of Diseases,Beijing 100730,China;Department of Endocrinology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences,Beijing 100730,China;Beijing Obstetrics and Gynecology Hospital,Capital Medical University,Beijing 100026,China;Department of Pharmacy,Air Force Hospital of Easter Theater Command,Nanjing Jiangsu 210002,China;Department of Pharmacy,Handan First Hospital,Handan Hebei 056000,China;Department of Pharmacy,Affiliated Hospital of Chengdu University,Chengdu Sichuan 610016,China;Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China)
出处 《中国药物警戒》 2022年第12期1376-1379,共4页 Chinese Journal of Pharmacovigilance
基金 国家科技重大专项重大新药创制(2019ZX09734001)。
关键词 胰岛素过敏 胰岛素自身抗体 暴发性1型糖尿病 药学监护 insulin allergy insulin autoantibody fulminant type 1 diabetes pharmaceutical care
  • 相关文献

二级参考文献4

共引文献1

同被引文献16

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部